
Biographie pas encore disponible.
Événements
21
Mar
2024
2:00 pm
Thèse
Thèse de Nesrine Safia RACHEDI
« Rôle du remodelage de la matrice extracellulaire dans la reprogrammation des cellules vasculaires pulmonaires au cours de l’hypertension artérielle pulmonaire » […]
IPMC
12
Juil
2024
Conférence
T. BERTERO invite le Dr Stephen Y CHAN
« Developing a precision medicine approach to vascular inflammation and pulmonary hypertension»
IPMC
Publications
2024
GLS2 links glutamine metabolism and atherosclerosis by remodeling artery walls.,
Nat Cardiovasc Res 2024 Nov; (): .
2024
Mechano-dependent sorbitol accumulation supports biomolecular condensate.,
Cell 2024 Nov; (): .
2024
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.,
Cell Metab 2024 Jun; 36(6): 1335-1350.e8.
2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.,
Arterioscler Thromb Vasc Biol 2019 Aug; 39(8): 1667-1681.
2019
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.,
Expert Opin Ther Targets 2019 Jun; 23(6): 511-524.
2019
UBTD1 is a mechano-regulator controlling cancer aggressiveness.,
EMBO Rep 2019 Apr; 20(4): .
2019
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.,
Circulation 2019 Feb; 139(7): 932-948.
2019
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy.,
Cell Metab 2019 Jan; 29(1): 124-140.e10.
2018
Longitudinal Evaluation of Pulmonary Arterial Hypertension in a Rhesus Macaque (Macaca mulatta) Model of HIV Infection.,
Comp Med 2018 Dec; 68(6): 461-473.
2018
Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells.,
Cancer Res 2018 Sep; 78(18): 5229-5242.
2018
Factors Associated with Heritable Pulmonary Arterial Hypertension Exert Convergent Actions on the miR-130/301-Vascular Matrix Feedback Loop.,
Int J Mol Sci 2018 Aug; 19(8): .
2016
p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.,
Genes Dev 2016 Dec; 30(23): 2623-2636.
2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.,
J Clin Invest 2016 Sep; 126(9): 3313-35.
2015
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts.,
Nat Commun 2015 Dec; 6(): 10204.
2015
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.,
Sci Rep 2015 Dec; 5(): 18277.
2015
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.,
Cell Rep 2015 Nov; 13(5): 1016-32.
2015
The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension.,
J Biol Chem 2015 Jan; 290(4): 2069-85.
2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.,
J Clin Invest 2014 Aug; 124(8): 3514-28.
2014
miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.,
Carcinogenesis 2014 May; 35(5): 1110-20.
2011
miR-483-3p controls proliferation in wounded epithelial cells.,
FASEB J 2011 Sep; 25(9): 3092-105.
2011
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.,
Cell Death Differ 2011 Mar; 18(3): 465-78.
2009
Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions.,
PLoS One 2009 Aug; 4(8): e6718.